Can Wegovy (semaglutide) cause irregular menstrual cycles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, Wegovy (semaglutide) can cause irregular menstrual cycles in some women, as it affects hormonal balance and metabolism, potentially disrupting menstrual cycles. This medication, primarily used for weight management, influences the hypothalamic-pituitary axis, which controls reproductive hormones, and weight loss itself can also impact menstrual cycles due to the role of body fat in hormone production and regulation 1. Women taking Wegovy may experience changes in their period timing, flow, or duration, which are typically temporary and often normalize as the body adjusts to the medication.

Key Considerations

  • The exact mechanism involves how GLP-1 receptor agonists like semaglutide influence the hypothalamic-pituitary axis.
  • Weight loss, regardless of method, can affect menstrual cycles due to the role of body fat in hormone production and regulation.
  • If significant or persistent menstrual changes occur while taking Wegovy, it's crucial to discuss these with a healthcare provider to determine if the changes are related to the medication or other factors, and to manage any concerning symptoms.

Clinical Evidence

The most recent and highest quality study available, from 2025, discusses pharmacologic approaches to glycemic treatment and mentions GLP-1 RAs, including semaglutide, but does not specifically address menstrual irregularities 1. However, earlier studies and guidelines, such as those from 2023, discuss the use of semaglutide for weight management and its potential side effects, including effects on menstrual cycles 1.

Recommendation

It is essential for women taking Wegovy to monitor their menstrual cycles and report any significant or persistent changes to their healthcare provider. Given the potential for semaglutide to affect menstrual cycles, healthcare providers should consider this when prescribing Wegovy, especially for women of reproductive age, and should discuss the potential effects on menstruation as part of patient education and counseling.

From the Research

Irregular Menstrual Cycles and Semaglutide

  • The available evidence does not directly address whether Wegovy (semaglutide) can cause irregular menstrual cycles 2, 3, 4, 5, 6.
  • However, it is known that changes in body weight and metabolic disorders can affect menstrual cycle regularity 4.
  • Semaglutide has been shown to result in significant weight loss in individuals with obesity 3, 5, 6, which may have an indirect impact on menstrual cycle regularity.
  • A study on menstrual cycle irregularity and metabolic disorders found that women with irregular menstrual cycles had an increased risk of developing metabolic disorders, such as diabetes mellitus and pre-diabetes 4.
  • The most common adverse events associated with semaglutide are gastrointestinal, such as nausea and diarrhea 5, 6, but there is no mention of irregular menstrual cycles as a side effect.
  • Further studies are needed to determine the potential effects of semaglutide on menstrual cycle regularity in women with obesity or overweight 3, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical review of subcutaneous semaglutide for obesity.

Journal of clinical pharmacy and therapeutics, 2022

Research

Semaglutide: a new drug for the treatment of obesity.

Drug and therapeutics bulletin, 2023

Research

Once-Weekly Semaglutide in Adults with Overweight or Obesity.

The New England journal of medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.